Islam with the internet could do much to prevent disease by Husseini, Abdullatif & Ronald, Laporte
See	discussions,	stats,	and	author	profiles	for	this	publication	at:	https://www.researchgate.net/publication/11780968
Islam	with	the	internet	could	do	much	to	prevent
disease
Article		in		BMJ	Clinical	Research	·	October	2001
DOI:	10.1136/bmj.323.7314.694b	·	Source:	PubMed
READS
14
2	authors:
Abdullatif	Husseini
Birzeit	University
107	PUBLICATIONS			3,664	CITATIONS			
SEE	PROFILE
Ronald	Laporte
University	of	Pittsburgh
364	PUBLICATIONS			12,917	CITATIONS			
SEE	PROFILE
Available	from:	Abdullatif	Husseini
Retrieved	on:	11	August	2016
Pickup and Keen emphasise the need to
limit the availability of subcutaneous insulin
infusion for use from specialist centres—
although financial costs may not be com›
paratively high, the treatment is expensive in
patient and professional time to ensure
safety. Pickup and Keen do not define
specialist centres—I suggest that physicians
should avoid being coerced into dabbling in
pump therapy by patients or pressure
groups.
G Knight consultant physician
Rotherham General Hospitals NHS Trust,
Rotherham General Hospital, Rotherham S60 2UD
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Intracranial hypertension and
nasal fluticasone propionate
Editor—Bond et al said that nasal flutica›
sone propionate caused benign intracranial
hypertension in a 13 year old boy with a his›
tory of Crohn’s disease and subsequently
reported this to the Committee on Safety of
Medicines.1 We have numerous problems
with this hypothesis. Firstly, Bond et al did
not confirm the diagnosis of intracranial
hypertension as the cerebrospinal fluid
pressure, which should be markedly raised,
was not measured on any occasion.2 Their
conclusions can thus at best be based only
on papilloedema, headache, and backache.
The boy was seen by specialists from the
ear, nose, and throat department, but no
mention was made of the presence or
absence of the otological manifestations,
which include objective pulsatile tinnitus
and low frequency hearing loss, which can
be the major or only manifestation of this
syndrome.3 Other recognised associated
conditions were not excluded, such as
hypervitaminosis A, systemic lupus erythro›
matosis, hypothyroidism and its correction,
and malnutrition and renutrition, which is
not unheard of in patients with Crohn’s dis›
ease; the patient was in remission, so both
factors could have been at work.4
We have to assume that this teenage
patient was not receiving any other drugs
such as tetracyclines or isotretinoin (com›
monly used in the treatment of acne in ado›
lescents), which also have been implicated in
the development of benign intracranial
hypertension. The condition tends to be self
limiting, with a course of less than 12
months in most cases and recurrence in
10%.5 We were therefore concerned that the
temporal relation that Bond et al describe
may just be the normal course for the condi›
tion. It is paradoxical that steroids are impli›
cated as an aetiological factor and are also
an accepted treatment. Would Bond et al
suggest that nasal steroids could in different
circumstances be a useful treatment?
In these days of evidence based medi›
cine there are several tests of causation that a
hypothesis or proposal should be subjected
to, and Bond et al have not done this. All cli›
nicians should be observant of adverse drug
reactions, with particular reference to
topical nasal steroids and children.
Michael Oko specialist registrar in otolaryngology
cybersurgeon@moko.freeserve.co.uk
Andrew Johnston consultant otolaryngologist
Monklands Hospital, Monkscourt Avenue, Airdrie
ML6 OJS
Iain R C Swan senior lecturer in otolaryngology
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Ultrasonography may have role
in assessing spontaneous
miscarriage
Editor—Ankum et al’s regular review on
the management of spontaneous miscar›
riage suggests that medical management is
of little benefit in the treatment of incom›
plete miscarriage.1 The wide variation in
reported success rates might, however, be
responsible for differences in the use of
ultrasonography.
The use of ultrasonography to deter›
mine whether there are retained products of
conception will exclude about 30% of
women from treatment as they will be found
to have an empty uterus.2 If ultrasonography
is not used at this stage the success rate will
be inflated by the inclusion of women having
unnecessary treatment. Conversely, the use
of ultrasonography to assess completeness
after uterine evacuation may reduce the
apparent success rates: the finding of
intrauterine tissue usually leads to an
assumption that the treatment has failed.
The clinical course of this finding, however,
is unknown, and most of these women will
probably complete the spontaneous miscar›
riage without further intervention.
Analysis of the available studies shows a
clear relation between the reported success
rates and the time at which the ultrasono›
graphy was carried out after treatment
(figure). The analysis suggests that the low
reported success rates in some studies
occurred as a result of an over›reaction to
ultrasonographic findings that are of unde›
termined relevance. Initial medical treat›
ment followed by expectant management
may be the key to the effective management
of incomplete miscarriages. These findings
also add weight to the arguments in favour
of using expectant management alone.
These two regimens need to be compared.
The figure may represent the natural
course of incomplete miscarriages, but this
needs to be confirmed in a prospective
ultrasonographic study of women having
expectant management.
Andrew Weeks lecturer in obstetrics and gynaecology
Department of Obstetrics and Gynaecology,
Makerere University, PO Box 7072, Kampala,
Uganda
aweeks@doctors.org.uk
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Islam with the internet could
do much to prevent disease
Editor—Modern public health has paid
little attention to prevention tailored
towards Muslims even though the Islamic
population now numbers over 1 billion.
Religion is a major component of the social
life of many communities throughout the
world, but in disease prevention we often use
the concept of “one size fits all,” with little
recognition of religion or culture. Religion’s
positive influences can be incorporated into
a strategy for health promotion and disease
prevention by using recent developments in
information technology.1
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Our goal is to provide access to scientifi›
cally sound and culturally acceptable infor›
mation on health promotion and disease
prevention to all who need it, using the
information superhighway. This resource
will have a major role in the accumulation
and dissemination of information to those
who need it the most.2
Islam as a religion puts a considerable
emphasis on health, and a wealth of
scientifically sound information on different
health issues is provided.3 We have started to
develop a network of professionals inter›
ested in Islam, the internet, and disease pre›
vention from all parts of the world. This
network is open to anyone interested in
exploring the wealth of information that
religious sources have on mental, physical,
and social health and can be accessed
from the homepage of the Islamic Global
Health Network (http://islamicprevention.
homestead.com/).
To improve global health we need to har›
ness the new technology of the internet, as
the largest factor in prevention is information
sharing. Less than 5% of the world is
connected to the internet, but Islam—like
most religions—is good at reaching the poor,
who have the highest disease burden. The
internet alone cannot reach across the health
and digital gap but when connected with
Islam and other religions it could have a pow›
erful effect in disseminating the most potent
prevention systems worldwide.
An internet based Islamic supercourse
(www.pitt.edu/∼super1/ighn.htm) includes a
variety of lectures on Islam and health and
other topics. Since this is an exploration into
the impact of religion on our holistic concept
of health, research into this area will be
important for all religions. We invite pro›
fessionals of all faiths to join this global
community.
Abdullatif Husseini coordinator
Epidemiology Unit, Institute of Community and
Public Health, Birzeit University, PO Box 14, Birzeit,
Palestine
islamicprevention@hotmail.com
Ronald E LaPorte director
Disease Monitoring and Telecommunications,
WHO Collaborating Center, University of
Pittsburgh, Pittsburgh, PA 15213, USA
This letter was prepared by Abdullatif Husseini and
Ronald E LaPorte on behalf of members of Islamic
Global Health Network (http://islamicprevention.
homestead.com/).
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Removal of thioridazine from
primary care formulary will
result in prescribing vacuum
Editor—Recently the Committee on the
Safety of Medicines recommended that gen›
eral practitioners should not prescribe
thioridazine.1 It recommended that prescrib›
ing should be limited to second line
treatment in schizophrenia and that pre›
scription should be initiated only by a
consultant psychiatrist. The reason was that
the drug was thought to be a cause of very
rare cardiac deaths by widening the QT
interval in an electrocardiogram, leading to
a greater risk of developing arrhythmias.
The evidence base to substantiate this
decision is not, however, sufficient. Thiori›
dazine is the most commonly prescribed
phenothiazine in primary care.2 Its implica›
tion in very rare deaths would not be substan›
tiated if number of deaths were directly
standardised to volume of phenothiazine
prescribed. In 1997 the Royal College of Psy›
chiatrists produced a council report on the
association between phenothiazines and sud›
den death.3 The report showed that sudden
death was associated with all the phenothi›
azines prescribed in primary care. The
phenothiazine associated with most deaths
was not thioridazine but chlorpromazine.
The report documented that abnormalities in
an electrocardiogram are comparatively
common in people receiving neuroleptics,
occurring in around 25%. It also stated that
such changes are commonly considered
benign; even now consensus on the clinical
significance of prolonged QTc is lacking.
Removing thioridazine from the pri›
mary care formulary will lead to a prescrib›
ing vacuum, and it is unfortunate that more
thought has not been given to which drugs
will fill it. As thioridazine has become an
adequate substitute for the prescribing of
benzodiazepines in conditions of anxiety
and irritability, its removal from the primary
care formulary will increase the probability
of benzodiazepines being overprescribed in
primary care. Perhaps the Committee on the
Safety of Medicines should have stood by its
original advice in 1996 when it suggested
that, whenever possible, drugs associated
with QT interval prolongation should be
avoided in patients who have underlying
cardiac disease.4
Perhaps the committee singled out
thioridazine as a result of the work by Reilly
et al, who measured a prolonged QT
interval in 495 patients.5 The cohort had
been prescribed a wide variety of psycho›
tropic drugs, and no single drug was
immune from being associated with a
widening of the QT interval. The paper con›
cluded that QT interval abnormalities are
surrogate markers, and the link between
psychotropic drugs, arrhythmia, and sudden
death should be examined. It is unfortunate
that this recommendation was not explored
before the the Committee on the Safety of
Medicines advised the removal of thiori›
dazine from the primary care formulary.
Nat Wright general practice consultant in substance
misuse and homelessness
No Fixed Abode Health Centre for Homeless
People, Leeds LS9 8AA
nat.wright@virgin.net
1 Committee on the Safety of Medicines. Thioridazine:
restricted indications and new warnings on cardiotoxicity.
London: CSM, 2000.
2 Prescription Pricing Authority. PACT standard report. New›
castle upon Tyne: PPA, 1999.
3 Royal College of Psychiatrists. The association between anti›
psychotic drugs and sudden death. Council Report CR57. Lon›
don: RCP, 1997.
4 Committee on the Safety of Medicines. Drug›induced pro›
longation of the QT interval. Curr Probl Pharmacovigilance
1996;22:2.
5 Reilly JG, Ayis S, Ferrier I, Jones S, Thomas S. QTc›interval
abnormalities and psychotropic drug therapy in psychiat›
ric patients. Lancet 2000;355:1048›52.
“Coronary heart disease” is not
tautologous
Editor—Gilroy repeats a common miscon›
ception in suggesting that the term “coron›
ary heart disease” is a new term and that it is
a tautology.1 It is an established North
American term, to be preferred to the
British synonym “ischaemic heart disease,”
which dominates recent editions of the Inter›
national Classification of Diseases.2 Ischaemic
is imprecise and could, as Friedberg pointed
out 35 years ago, apply equally well to heart
disease secondary to stenosis of the aortic
valve, or even to anaemia.3 “Coronary” does
not mean cardiac but “resembling, or encir›
cling, like a crown.”4 It was the 17th century
anatomists’ descriptive name for the arterial
pattern around the heart.
Coronary artery disease is used, confus›
ingly, to mean pathological findings confined
within the coronary arteries. These changes
are present in almost all adults and are
usually symptomless. It is only when changes
to the coronary arteries are severe enough to
affect the myocardium, to cause coronary
heart disease, that patients are truly
diseased—from angina, myocardial infarction,
sudden death, or heart failure. Coronary
heart disease means that the heart as an
organ is involved, necessitating secondary
prevention, whereas we all have coronary
artery disease for decades beforehand and try
to slow its progression to heart disease by pri›
mary prevention. Heart disease and heart
attacks are too non›specific as terms to get by
without qualification. Twenty five years ago I
tried to introduce “coronary heart attack” as a
generic term to cover both cardiac infarction
and coronary deaths (often unassociated with
infarction), but without success.5
Hugh Tunstall›Pedoe professsor of cardiovascular
epidemiology
Cardiovascular Epidemiology Unit, Ninewells
Hospital and Medical School, University of Dundee,
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